Understanding the immune response after mild TBI: Do endothelial cells play a major role?
了解轻度 TBI 后的免疫反应:内皮细胞发挥主要作用吗?
基本信息
- 批准号:10227663
- 负责人:
- 金额:$ 4.16万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-01 至 2022-06-30
- 项目状态:已结题
- 来源:
- 关键词:3-DimensionalAcuteAddressAffectAlzheimer&aposs DiseaseAnimalsAntibodiesArteriesAstrocytesBehaviorBlood - brain barrier anatomyBlood VesselsBlood capillariesBlood flowBrainBrain DiseasesBrain InjuriesCellsCentral Nervous System DiseasesCerebrovascular CirculationChronicClosed head injuriesCognitiveConfocal MicroscopyDevelopmentDiffusionDiseaseEkoEndothelial CellsEndotheliumEnvironmentFDA approvedFluorescence-Activated Cell SortingFluorescent DyesFutureGene Expression ProfilingGenesGrowth FactorHemagglutininHistologyHourHumanImageImmuneImmune responseImmunohistochemistryIndividualInflammationInflammatoryInflammatory ResponseInfluenza HemagglutininInjuryInterleukin-1Interleukin-1 ReceptorsKnock-outLabelLinkLocationMediatingMediator of activation proteinMessenger RNAMinorityModelingMusNeurodegenerative DisordersNeuroimmuneOperative Surgical ProceduresOrangesPathologyPathway interactionsPatientsPatternPericytesPhysiologicalPlayPositioning AttributePostdoctoral FellowProteinsRNARecoveryReporterRoleScientistSeveritiesSignal TransductionStructureTechniquesTestingTherapeuticTimeTrainingTraumatic Brain InjuryUnited StatesVascular DiseasesVeinsWorkangiogenesisbrain endothelial cellcareercell cortexchemokinecytokinedensityexperiencefunctional outcomesgenetic manipulationimprovedlipophilicitymild traumatic brain injurynano-stringneuroinflammationneurovascular unitpersistent symptomreceptorreconstructionred fluorescent proteinresponseskillstomography
项目摘要
PROJECT SUMMARY/ABSTRACT:
The vast majority (over 90%) of traumatic brain injuries (TBI) are classified as mild TBI (mTBI). While most
individuals recover from mTBI quickly, a significant minority (10-15%) of patients with mTBI experience
persistent symptoms – there are no FDA approved treatments for these individuals. Chronic neuroinflammation
and vascular disruption following TBI create an unfavorable environment for recovery. More broadly,
neuroinflammation and vascular dysfunction are significant contributors to other CNS diseases as well,
including Alzheimer’s disease. My preliminary results demonstrate that interleukin-1 (IL-1) signaling through
interleukin-1 receptor 1 (IL-1R1) may be as a link between chronic neuroinflammation and vascular pathology
and serve as a therapeutic avenue. IL-1, a major pro-inflammatory cytokine, is upregulated following all TBI
severities. IL-1 release has been linked with downstream alterations of the vasculature, including changes to
the neurovascular unit, blood flow alteration, angiogenesis, and increased release of cytokines, chemokines,
and growth factors. We have found that brain endothelial cells express a high number of IL-1R1 receptors.
Further, we have demonstrated that mice lacking IL-1R1 show reduced neuroinflammation following
experimental mTBI. We hypothesize that following mTBI, brain endothelial cells, specifically through IL-
1R1, act as a mediator of the neuroimmune and vascular responses. To test this hypothesis, we will use a
closed head injury model (CHI) to model a mTBI in mice. Further, we will manipulate IL-1R1 using an inducible
endothelial cell-specific IL-1R1 knockout (eKO), a global knockout in which IL-1R1 has been restored only in
the endothelial cells (eRestore), and an IL-1R1 reporter mouse in which the protein and mRNA are labeled. In
aim 1, we will determine the cellular and temporal expression changes of IL-1R1 in the brain following CHI
using the reporter mice. Through this aim, I will be able to determine how TBI alters IL-1R1 across time as well
as IL-1R1 association with arteries, veins, and capillaries, while also honing my skills in histology techniques.
In aim 2, we will delineate endothelial IL-1R1-dependent neuroinflammatory responses following CHI in
wildtype, eKO, and eRestore mice. Through this aim, I will get experience in animal surgeries as well as RNA
isolation and Nanostring gene expression analysis. Finally, in aim 3, we will investigate the involvement of
endothelial IL-1R1 in vascular structure and blood flow changes after TBI. To do this, we will use vessel
painting and speckle contrast diffusion correlated tomography (scDCT). If we find support for our hypothesis,
we will provide the groundwork for the development of IL-1 therapeutics for the treatment of mTBI, as well as
describe a physiological response of the CNS that can be applied to other diseases. Overall, the question
outlined in this proposal not only moves the field forward but also provides significant scientific training which
will position me as a strong candidate for post-doctoral work and a future career as an independent scientist.
项目摘要/摘要:
绝大多数(超过90%)的创伤性脑损伤(TBI)被归类为轻度脑损伤(MTBI)。虽然大多数人
个人从mTBI中恢复得很快,相当少数(10%-15%)的mTBI患者有过这样的经历
持续性症状--FDA没有批准针对这些人的治疗方法。慢性神经炎
而颅脑损伤后的血管破裂为康复创造了不利的环境。更广泛地说,
神经炎症和血管功能障碍也是其他中枢神经系统疾病的重要因素,
包括阿尔茨海默氏症。我的初步结果表明,白介素1(IL-1)通过
白细胞介素1受体1(IL-1R1)可能是慢性神经炎和血管病变之间的联系
作为一种治疗途径。IL-1是一种主要的促炎细胞因子,在所有脑损伤后上调
严肃性。IL-1的释放与下游血管系统的变化有关,包括
神经血管单位,血流改变,血管生成,细胞因子,趋化因子,
和增长因素。我们发现脑内皮细胞表达大量的IL-1R1受体。
此外,我们还证明,缺乏IL-1R1的小鼠表现出以下神经炎症的减轻
实验性mTBI。我们假设,在mTBI后,脑内皮细胞,特别是通过IL-1-
1R1,作为神经免疫和血管反应的中介。为了检验这一假设,我们将使用
闭合性脑损伤模型(CHI),建立小鼠脑创伤模型。此外,我们将使用诱导物操纵IL-1R1
内皮细胞特异性IL-1R1基因敲除(EKO),在这种全球基因敲除中,IL-1R1仅在
内皮细胞(ERestore),以及标记了蛋白质和mRNA的IL-1R1报告小鼠。在……里面
目的1、测定慢性脑损伤后脑组织IL-1R1的细胞和时间表达变化
使用的是报告老鼠。通过这个目标,我也将能够确定脑损伤是如何随时间改变IL-1R1的
因为IL-1R1与动脉、静脉和毛细血管联系在一起,同时也磨练了我在组织学技术方面的技能。
在目标2中,我们将描绘血管内皮细胞IL-1R1依赖的神经炎性反应
野生型、Eko和eRestore小鼠。通过这个目标,我将获得动物手术和RNA方面的经验
纳米串基因的分离和表达分析。最后,在目标3中,我们将调查
颅脑损伤后血管结构和血流量中内皮细胞IL-1R1的变化要做到这一点,我们将使用容器
绘画和散斑对比扩散相关层析成像(ScDCT)。如果我们发现我们的假设得到了支持,
我们将为IL-1治疗脊髓损伤的治疗药物的开发提供基础,以及
描述一种可应用于其他疾病的中枢神经系统的生理反应。总体而言,这个问题
这份提案中概述的内容不仅推动了该领域的发展,而且还提供了重要的科学培训,
将使我成为博士后工作的有力候选人,并成为未来独立科学家的职业。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Colleen Bodnar其他文献
Colleen Bodnar的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 4.16万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 4.16万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 4.16万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 4.16万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 4.16万 - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 4.16万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 4.16万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 4.16万 - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 4.16万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
$ 4.16万 - 项目类别:
Standard Grant














{{item.name}}会员




